Curiox - Laminar Wash Auto 1000 System

Back to product overview

Contact us
Downloads

SINGAPORE

Robert Puschmann, Vice President, Business Unit Technology, Singapore, Malaysia, and Vietnam, Digital and Operational Excellence

Phone +65 6471 1466

Contact Email

DKSH Singapore Pte Ltd
625 Lorong 4 Toa Payoh, #03-00
319519 Singapore
Singapore

NEW ZEALAND

Benoit Fissot, General Manager, Technology, Australia & New Zealand

Phone 0800 951 010

Contact Email

DKSH New Zealand Limited
33 Westpoint Drive
0618 Hobsonville, Auckland
New Zealand

THAILAND

Oliver Hammel, Vice President

Phone +66 2 639 7000

Contact Email

DKSH Technology Limited (Head Office)
2533 Sukhumvit Road, Bangchak, Phrakhanong
10260 Bangkok
Thailand

Laminar Wash™ AUTO1000 System Brochure - Protected
(PDF, 993 KB)

Accelerate high-throughput flow and mass cytometry workflows with fully automated sample preparation.

The Laminar Wash AUTO 1000 System eliminates time-consuming and labor-intensive manual pipetting and handling by automating the complete surface and intracellular staining workflow for flow and mass cytometry. You get all the benefits of laminar washing in a completely automated system.

Technical Specifications

Voltage Requirements	100-240V
Power Consumption	+42V/5.0A
Dimensions	89 cm H x 71 cm W x 136 cm D
35.0 in H x 27.9 in W x 53.5 in D	35.0 in H x 27.9 in W x 53.5 in D
Weight	120kg (264.5 lbs)

Key Features

Auto 1000

The same data quality, cell retention, cell viability, and reproducibility benefits of the HT2000 and Mini systems
A pre-programmed, ready-to-use solution covering the entire sample prep workflow
An intuitive user interface that is easily programmed for those new to automation as well as automation experts
Electronic files that can track and trace samples
The reduction in operator-to-operator variability that automation provides

AUTO1000: Automate Your Cell Staining Workflow

Curiox was founded in 2008 to commercialize DropArray™ technology, which was initially developed by Namyong Kim, PhD and his group at the Institute of Bioengineering and Nanotechnology (IBN), a part of A*STAR. The venture was backed by Nanostart AG and Exploit Technologies, the commercialization arm of A*STAR.

We look forward to ushering in the next generation of innovations that accelerate the pace of life science research, diagnostics, and therapeutics discovery and development.